IFNA1 and autoimmune disease: Despite the therapeutic utility of IFN-α and TNF-α antagonists in human diseases, these agents have been implicated in the induction of autoimmune diseases [21], including sarcoidosis, with more than 30 cases of TNF-α antagonist-induced sarcoidosis reported [22]–[26].